These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab. Yamada K; Baba A; Kanekura T J Eur Acad Dermatol Venereol; 2024 Sep; 38(9):e750-e752. PubMed ID: 38358063 [No Abstract] [Full Text] [Related]
16. Successful treatment of acquired reactive perforating collagenosis with itraconazole. Ye B; Cao Y; Liu Y Eur J Med Res; 2021 Jul; 26(1):74. PubMed ID: 34256825 [TBL] [Abstract][Full Text] [Related]
17. Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer. Tsutsui K; Namikawa K; Mori T; Kato K; Jinnai S; Nakama K; Ogata D; Takahashi A; Yamazaki N J Dermatol; 2021 Feb; 48(2):e114-e115. PubMed ID: 33264448 [No Abstract] [Full Text] [Related]
18. Treatment of pruritus of reactive perforating collagenosis using transcutaneous electrical nerve stimulation. Chan LY; Tang WY; Lo KK Eur J Dermatol; 2000; 10(1):59-61. PubMed ID: 10694302 [TBL] [Abstract][Full Text] [Related]
19. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease. Calista D; Morri M Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600 [No Abstract] [Full Text] [Related]
20. Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease. Huseynova L; Akdogan N; Gököz Ö; Evans SE An Bras Dermatol; 2020; 95(3):336-339. PubMed ID: 32359703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]